Chantix Faces Further FDA Scrutiny
The Food and Drug Administration (FDA) may issue a revision of its warning on Pfizer's controversial smoking-cessation drug Chantix, the Wall Street Journal reported Oct. 23.
Just a few months after Pfizer relaunched television advertisements for the drug, the Institute for Safe Medication Practices released a report highlighting 1,001 recent, serious incidents involving Chantix. Of these, 15 were related to traffic accidents and 52 were connected to blackouts.
"The most alarming thing about the numbers is the increase in loss of consciousness like a blackout, and the sudden [temporary] loss of vision," said report co-author Curt Furberg, a professor at Wake Forest University's medical school. "That's potentially very dangerous for everyone, as the traffic-accident numbers show."
Read the full story here
IWanttoQuitSmoking.com Hypnosis Link
Just a few months after Pfizer relaunched television advertisements for the drug, the Institute for Safe Medication Practices released a report highlighting 1,001 recent, serious incidents involving Chantix. Of these, 15 were related to traffic accidents and 52 were connected to blackouts.
"The most alarming thing about the numbers is the increase in loss of consciousness like a blackout, and the sudden [temporary] loss of vision," said report co-author Curt Furberg, a professor at Wake Forest University's medical school. "That's potentially very dangerous for everyone, as the traffic-accident numbers show."
Read the full story here
IWanttoQuitSmoking.com Hypnosis Link
Search our Hypnosis Site below:
posted by Mark Barrus (888) 865 -1870 @ 1:43 PM
Links to this post:
Create a Link
<< Home